Results 221 to 230 of about 50,110 (265)
Some of the next articles are maybe not open access.
Hematology/Oncology Clinics of North America
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Cutaneous T-cell lymphoma in a cat
Journal of the American Veterinary Medical Association, 1994An 8-year-old castrated male cat was examined because of a chronic, nonhealing, ulcerative lesion on the left hind limb. Cutaneous lymphoma was diagnosed on the basis of the morphologic appearance of malignant cells and Pautrier's microabscesses on light and electron microscopic examination.
J C, Tobey +4 more
openaire +2 more sources
Necrobiotic cutaneous T-cell lymphoma
Journal of the American Academy of Dermatology, 1999We report 3 patients with granulomatous cutaneous T-cell lymphoma (CTCL) who showed necrobiosis histologically with palisading granulomas. Although granulomatous change may be present in up to 4% of cases of CTCL, necrobiosis is rare. Misdiagnosis may occur if epidermotropism is minimal or if atypical cells are masked by the granulomatous infiltrate. T-
A, Woollons +4 more
openaire +2 more sources
Overview of Cutaneous T-Cell Lymphomas
Hematology/Oncology Clinics of North America, 2019Non-Hodgkin's lymphoma (NHL) encompasses a diverse collection of systemic and primary cutaneous lymphomas. Cutaneous T-cell lymphomas (CTCLs) represent about 13% of all NHLs, which are further subdivided into a heterogeneous group with vastly different presentations and histologic features.
Cecilia A, Larocca, Nicole R, LeBoeuf
openaire +2 more sources
Seminars in Oncology Nursing, 1991
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
openaire +2 more sources
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
openaire +2 more sources
Vorinostat in cutaneous T-cell lymphoma
Drugs of Today, 2007Histone deacetylase inhibitors (HDAC-Is) are a novel class of small molecules being evaluated in clinical trials for a number of different malignancies. HDAC-Is are able to induce differentiation, apoptosis and/or cell cycle arrest of malignant cells selectively.
Madeleine, Duvic, Jenny, Vu
openaire +2 more sources
Phototherapy for cutaneous T-cell lymphoma
Dermatologic Therapy, 2003Phototherapy has been utilized for decades in the treatment of various dermatologic conditions, including cutaneous T-cell lymphoma (CTCL). Currently, a number of light sources are available, and selection of the specific modality is based on a number of factors, the most important of which is disease stage. The efficacy of broadband ultraviolet B (UVB)
Elma D, Baron, Seth R, Stevens
openaire +2 more sources
Romidepsin for Cutaneous T-Cell Lymphoma
Future Oncology, 2013Cutaneous T-cell lymphomas are relatively rare lymphomas and the most common form is mycosis fungoides. Its rare leukemic variant is Sezary syndrome. Advanced-stage disease is typically treated with bexarotene (a retinoid), IFN-α or conventional chemotherapeutic agents, but relapses are inevitable.
H Miles, Prince +2 more
openaire +2 more sources
Cutaneous T-cell lymphoma: A review
Critical Reviews in Oncology/Hematology, 1983Cutaneous T-cell lymphomas define a spectrum of disorders associated with T-lymphocytic proliferation with clinical manifestations occurring in the skin during the course of the disease. This review has dealt with two rather uncommon disorders, namely mycosis fungoides and Sezary syndrome which are indolent malignant lymphomas, occurring primarily in ...
Charles F. Winkler +2 more
openaire +2 more sources
Phototherapy for Cutaneous T-Cell Lymphoma
Dermatologic Clinics, 2020Phototherapy with psoralen and ultraviolet A (PUVA) or narrowband-UVB (NBUVB) is frequently used for the patch and plaque stages of mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma. This article provides practical guidelines for the design and implementation of a phototherapy protocol for early stage MF, including an overview ...
Arthur, Marka, Joi B, Carter
openaire +2 more sources